Literature DB >> 1736035

The exogenous origin of trimethylamine in the mouse.

M al-Waiz1, M Mikov, S C Mitchell, R L Smith.   

Abstract

Although it is now generally regarded that the origin of urinary trimethylamine (TMA) is via the action of intestinal microflora on precursors such as choline, little direct evidence exists. The normal production of urinary TMA was shown to be absent in germ-free mice and greatly reduced in antibiotic-pretreated animals. Cohabitation of germ-free mice with conventional animals restored their ability to excrete TMA. This study invokes a fundamental role for the intestinal microflora in the provision of TMA from precursors within the food.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1736035     DOI: 10.1016/0026-0495(92)90140-6

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  77 in total

1.  The role of the gut microbiota in nonalcoholic fatty liver disease.

Authors:  Ahmed Abu-Shanab; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

2.  Increased circulating choline, L-carnitine and TMAO levels are related to changes in adiposity during weight loss: role of the gut microbiota?

Authors:  Ellen E Blaak; Emanuel E Canfora
Journal:  Ann Transl Med       Date:  2018-12

3.  Neonatal environment exerts a sustained influence on the development of the intestinal microbiota and metabolic phenotype.

Authors:  Claire A Merrifield; Marie C Lewis; Bernard Berger; Olivier Cloarec; Silke S Heinzmann; Florence Charton; Lutz Krause; Nadine S Levin; Swantje Duncker; Annick Mercenier; Elaine Holmes; Mick Bailey; Jeremy K Nicholson
Journal:  ISME J       Date:  2015-06-12       Impact factor: 10.302

4.  Involvement of a gut-retina axis in protection against dietary glycemia-induced age-related macular degeneration.

Authors:  Sheldon Rowan; Shuhong Jiang; Tal Korem; Jedrzej Szymanski; Min-Lee Chang; Jason Szelog; Christa Cassalman; Kalavathi Dasuri; Christina McGuire; Ryoji Nagai; Xue-Liang Du; Michael Brownlee; Naila Rabbani; Paul J Thornalley; James D Baleja; Amy A Deik; Kerry A Pierce; Justin M Scott; Clary B Clish; Donald E Smith; Adina Weinberger; Tali Avnit-Sagi; Maya Lotan-Pompan; Eran Segal; Allen Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-15       Impact factor: 11.205

5.  A complex microworld in the gut: gut microbiota and cardiovascular disease connectivity.

Authors:  Michael R Howitt; Wendy S Garrett
Journal:  Nat Med       Date:  2012-08       Impact factor: 53.440

Review 6.  Metabolomics in human type 2 diabetes research.

Authors:  Jingyi Lu; Guoxiang Xie; Weiping Jia; Wei Jia
Journal:  Front Med       Date:  2013-02-02       Impact factor: 4.592

7.  Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice.

Authors:  Marc-Emmanuel Dumas; Richard H Barton; Ayo Toye; Olivier Cloarec; Christine Blancher; Alice Rothwell; Jane Fearnside; Roger Tatoud; Véronique Blanc; John C Lindon; Steve C Mitchell; Elaine Holmes; Mark I McCarthy; James Scott; Dominique Gauguier; Jeremy K Nicholson
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-08       Impact factor: 11.205

Review 8.  Developing a metagenomic view of xenobiotic metabolism.

Authors:  Henry J Haiser; Peter J Turnbaugh
Journal:  Pharmacol Res       Date:  2012-08-09       Impact factor: 7.658

9.  Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk.

Authors:  W H Wilson Tang; Zeneng Wang; Bruce S Levison; Robert A Koeth; Earl B Britt; Xiaoming Fu; Yuping Wu; Stanley L Hazen
Journal:  N Engl J Med       Date:  2013-04-25       Impact factor: 91.245

10.  Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme.

Authors:  Smaranda Craciun; Emily P Balskus
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-14       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.